PNC Financial Services Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $570K | Buy |
|
|||||
|
2025
Q2 | $586K | Buy |
|
|||||
|
2025
Q1 | $495K | Buy |
|
|||||
|
2024
Q4 | $512K | Hold |
|
|||||
|
2024
Q3 | $271K | Buy |
|
|||||
|
2024
Q2 | $166K | Buy |
|
|||||
|
2024
Q1 | $117K | Buy |
|
|||||
|
2023
Q4 | $165K | Buy |
|
|||||
|
2023
Q3 | $114K | Sell |
|
|||||
|
2023
Q2 | $152K | Buy |
|
|||||
|
2023
Q1 | $150K | Buy |
|
|||||
|
2022
Q4 | $143K | Buy |
|
|||||
|
2022
Q3 | $139K | Buy |
|
|||||
|
2022
Q2 | $75K | Buy |
|
|||||
|
2022
Q1 | $36K | Buy |
|
|||||
|
2021
Q4 | $43K | Buy |
|
|||||
|
2021
Q3 | $36K | Hold |
|
|||||
|
2021
Q2 | $46K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2K | Buy |
|